In Situ Biomimetic Mineralization on ZIF-8 for Smart Drug Delivery.
ZIF-8
biomimetic mineralization
drug delivery
hydroxyapatite
lysozyme
Journal
ACS biomaterials science & engineering
ISSN: 2373-9878
Titre abrégé: ACS Biomater Sci Eng
Pays: United States
ID NLM: 101654670
Informations de publication
Date de publication:
10 08 2020
10 08 2020
Historique:
entrez:
18
1
2021
pubmed:
19
1
2021
medline:
15
5
2021
Statut:
ppublish
Résumé
The exploration of metal-organic frameworks (MOFs) with good biocompatibility and physiological stability as carrier platforms for biomedical applications is of great importance but remains challenging. Herein, we developed an in situ biomimetic mineralization strategy on zeolitic imidazolate framework (ZIF) nanocrystals to construct a drug release system with favorable cytocompatibility, improved stability, and pH responsiveness. With lysozyme (Lys) wrapped on the surface of Zn-based ZIF (ZIF-8), Lys/ZIF-8 could strongly bond metal ions to promote nucleation and growth of bone-like hydroxyapatite (HAp), leading to formation of HAp@Lys/ZIF-8 composites. In vitro investigations indicate that the composites with a hollow Lys/ZIF-8 core and a HAp shell exhibited a high drug-loading efficiency (56.5%), smart pH-responsive drug delivery, cytocompatibility, and stability under physiological conditions. The proposed biomimetic mineralization strategy for designing MOFs-based composites may open a new avenue to construct advanced delivery systems in the biomedical field.
Identifiants
pubmed: 33455195
doi: 10.1021/acsbiomaterials.0c00935
doi:
Substances chimiques
Metal-Organic Frameworks
0
Pharmaceutical Preparations
0
Zeolites
1318-02-1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM